Back to top

Welcome to MS Australia


MS Australia is very pleased to learn that Roche have announced the approval of Ocrevus (ocrelizumab) by the Therapeutic Goods Administration (TGA) for use in Australia.

Ocrevus can be used in treatment of both patients with relapsing remitting multiple sclerosis (RRMS) and primary progressive multiple sclerosis (PPMS) to delay the progression of physical disability. It is administered by intravenous (IV) infusion every 6 months.



I had my first attack when I was nine years old. The first thing I remember was finding it difficult to do up buttons. This was followed by weakness in my left arm and then problems with slurring words and my mouth dropping on the left side and problems closing my left eye. Then trouble walking, causing me to drag my left leg. I cannot remember being particularly concerned about what was happening to me but, in retrospect, I cannot begin to imagine what my mother must have been going through.My...


Trish ball

The Trish MS Research Foundation presents the Moulin Rouge Ball

Saturday 9th September
The Grand Ballroom Hilton Sydney
New South Wales

Tweets by @MS_Australia

Support & Services

As the national peak body for Australians living with MS, we work closely with the state MS societies to help you connect with the right support and services.


Support & Services